Keywords
intensive care unit
COVID-19
How to Cite
Abstract
Objective: To report the management and outcome of 64 patients admitted to the ICU during the second wave of COVID-19 covering a period of 90 days.
Design: Case series, prospective, observational, descriptive study.
Setting: Adult ICU.
Patients: With COVID-19 admitted to the ICU due to respiratory failure.
Variables of interest: Age, sex, APACHE II score, requirement of mechanical ventilation, prone position, neuromuscular blockade, vasopressors, renal replacement therapy, ventilator-associated pneumonia, pulmonary thromboembolism, multiple organ dysfunction.
Results: From a cohort of 95 admitted patients, 64 had a positive COVID-19 test. They were divided into two groups: survival group and non-survival group. The average age was 57 (male 68.75%). 92.10% required mechanical ventilation (median 10 days), without a significant difference between groups. 50% required the prone position, without significant difference between groups, but the survival group had more prone cycles. 81.30% required neuromuscular blockade. A high level of ventilator-associated pneumonia was observed (56.04%): 34.6% due to Klebsiella pneumoniae (KPC) and 42% of multiple organ dysfunction (p 0.0097). The initial APACHE II score was 15 (p 0.0013). The mortality rate was 68.8%.
Conclusions: Mortality rate was higher in groups with acute respiratory distress syndrome especially in males and in older patients. The most frequent complications were ventilation-associated pneumonia and multiple organ dysfunction.
References
2) Di Rienzo J.A., Casanoves F., Balzarini M.G., Gonzalez L., Tablada M., Robledo C.W. InfoStat versión 2020. Centro de Transferencia InfoStat, FCA, Universidad Nacional de Córdoba, Argentina. URL http://www.infostat.com.ar
3) OMS. Manejo clínico de la infección respiratoria aguda grave cuando se sospecha una infección por el nuevo coronavirus (nCoV). https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
4) Christian Karagiannidis*, Carina Mostert*, Corinna Hentschker,wt al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. The lancet Vol 8 September 2020. https://doi.org/10.1016/S2213-2600(20)30316-7
5) Xiaobo Yang*, Yuan Yu*, Jiqian Xu*, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet Vol 8 May 2020. https://doi.org/10.1016/S2213-2600(20)30079-5
6) Elisa Estenssoro, Cecilia I Loudet, Fernando G Ríos, et al. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. The lancet.com/respiratory Published online July 2, 2021 https://doi.org/10.1016/S2213-2600(21)00229-0
7) Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region Italy. JAMA. 2020, http://dx.doi.org/10.1001/jama.2020.5394.
8) Safiya Richardson, MD, MPH; Jamie S. Hirsch, MD,MA, MSB; Mangala Narasimhan, DO; et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA Published online April 22, 2020. doi:10.1001/jama.2020.6775
9) Silvio A. Namendys‑Silva, Alan Gutierrez‑Villasenor and Juan P. Romero‑Gonzalez. Hospital mortality in mechanically ventilated COVID‑19 patients in Mexico. Intensive Care Med 30 septiembre 2020. https://doi.org/10.1007/s00134-020-06256-3
10) Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315: 788–800.
11) Gomersall CD, Joynt GM, Lam P, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004; 30:381–87.
12) COVID-19 Perlas recomendaciones Ministerio de Salud de la Nación - Sociedad Argentina de Terapia Intensiva. Argentina.gob.ar/salud.
13) Dubin, Arnaldo; Estenssoro, Elisa. Ampliación de las recomendaciones sobre el uso de heparinas y corticoides. Sociedad Argentina de Terapia Intensiva. Ministerio de Salud Argentina. Argentina.gob.ar/salud.
14) COVID-19 - Falla respiratoria recomendaciones Ministerio de Salud de la Nación - Sociedad Argentina de Terapia Intensiva. Argentina.gob.ar/salud.
15) Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021; 384: 693–704.
16) Botta M, Tsonas AM, Pillay J, et al. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med 2021; 9: 139–48.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.